Novo Nordisk, the maker of these weight-loss drugs, does not include warnings about the increased risk of gastroparesis/stomach paralysis (frozen stomach) for people who consume the medications or receive GLP-1 RA treatments
These factors include the quantity and duration of alcohol consumption, the type of alcohol, drinking patterns, gender, ethnicity, obesity, hepatitis virus infection, genetic predisposition, and nutritional status (Pekarska and Parker, 2023
Droma, Y
BPC-157 can potentially treat issues that indirectly lower fertility, such as chronic pelvic inflammation, tissue scarring, and some gastrointestinal disorders
But its effectiveness doesnt end there
Regular monitoring ensures adjustments for optimal balance and minimal side effects